Delivery Order SPE2DR25D6048-SPE2DR26FATA0

<p>The Defense Logistics Agency issued a $1,402.67 delivery order to AmerisourceBergen Drug Corp on April 23, 2026, for atropine 1 mg/10 ml syringes under its Troop Support Medical indefinite delivery contract.</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is April 24, 2026. This is a firm fixed-price order with no set-aside applied.</p>

<p>The Defense Logistics Agency issued a $1,189.27 delivery order to Amerisourcebergen Drug Corp on March 5, 2026, for atropine 1 mg/10 ml syringes under its IDC with the DLA Troop Support Medical (valued at up to $999,999,999.00 through December 2026).</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of March 6, 2026. No set-aside was used.</p>

The Defense Logistics Agency issued a $1,073.74 delivery order to Amerisourcebergen Drug Corp on March 26, 2026, for atropine 1 mg/10 ml syringes (10 ml). This delivery order is issued under the DLA Troop Support Medical IDC, a $999,999,999 indefinite delivery contract running through December 2026 that enables pharmaceutical and medical supply procurement globally in support of military healthcare programs. Place of performance is Conshohocken, PA. The order carries a firm fixed price and has...

<p>The Defense Logistics Agency issued a $4,664.80 delivery order to AmerisourceBergen Drug Corp on April 14, 2026, for atropine 1 mg/10 mL syringes.</p> <p>The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. Ultimate completion date is April 15, 2026. Pricing is firm fixed price with no set-aside applied.</p>

The Defense Logistics Agency issued a $3,238.46 delivery order to Amerisourcebergen Drug Corp on March 4, 2026, for atropine 1 mg/10 ml syringes (10 ml). The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract running through December 2026 that supplies pharmaceutical products and medical supplies globally to support military healthcare programs. Place of performance is Conshohocken, PA. The order has a firm fixed-price structure with...

<p>The Defense Logistics Agency issued a $3,440.36 delivery order to Amerisourcebergen Drug Corp on February 24, 2026, for atropine 8 mg/20 mL vials under firm fixed-price terms.</p> <p>Place of performance is Conshohocken, PA. The order carries an ultimate completion date of February 25, 2026. The delivery order was issued without a set-aside.</p>

<p>The Defense Logistics Agency issued a $2,898.40 delivery order to Amerisourcebergen Drug Corp on April 21, 2026, for atropine 8 mg/20 ml vials.</p> <p>Place of performance is Conshohocken, PA. The order carries a firm fixed-price structure with an ultimate completion date of April 22, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency issued a $4,131.95 delivery order to Amerisourcebergen Drug Corp on March 12, 2026, for Atropine 1 mg/ml vial under a firm fixed-price structure with an ultimate completion date of March 13, 2026.</p> <p>Place of performance is Conshohocken, PA 19428. The order was not set-aside and carries a ceiling value of $4,131.95.</p>

The Defense Logistics Agency issued a $2,162.35 delivery order to Amerisourcebergen Drug Corp on April 16, 2026, for atropine 1 mg/ml vials. Place of performance is Conshohocken, PA. The order has a firm fixed-price structure with an ultimate completion date of April 17, 2026. This is a transactional pharmaceutical delivery order under Amerisourcebergen's standing indefinite delivery contract with DLA Troop Support Medical, which supports the Pharmaceutical Prime Vendor Global Program Generation...

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on April 13, 2026, for atropine 1 mg/ml vials, with a ceiling value of $3,887.00.</p> <p>Place of performance is Conshohocken, PA. The order carries an ultimate completion date of April 14, 2026, and is priced on a firm fixed-price basis. No set-aside was used.</p>